ARWR - Arrowhead Pharmaceuticals prices $450M common stock offering
2024-01-03 07:04:32 ET
More on Arrowhead Pharmaceuticals
- Arrowhead Pharmaceuticals: Transition To Commercialization
- Arrowhead Pharmaceuticals: Balance Sheet Concern Needs To Be Addressed
- Arrowhead Pharmaceuticals, Inc. (ARWR) Q4 2023 Earnings Call Transcript
- Arrowhead Pharmaceuticals Q4 2023 Earnings Preview
- GSK inks $1B deal to obtain rights to hepatitis B drug from J&J
For further details see:
Arrowhead Pharmaceuticals prices $450M common stock offering